PMID: 9167460May 24, 1997Paper

Reduction of trachoma in a sub-Saharan village in absence of a disease control programme

Lancet
P J DolinA Foster

Abstract

Trachoma is a leading cause of blindness in the developing world and is most prevalent among people who live in poor rural communities in arid locations. We analysed the results of surveys of trachoma prevalence in Marakissa, a rural village in The Gambia. These surveys were undertaken in 1959, by the Medical Research Council, and in 1987 and 1996 by the Gambian National Eye Care Programme. During this 37-year period, the prevalence of active inflammatory trachoma among children aged 0-9 years fell from 65.7 cases per 100 children in 1959 to 2.4 cases per 100 children in 1996. The prevalence also fell dramatically among people of 10-19 years (52.5 to 1.4 per 100) and among people of 20 years and older (36.7 to 0 cases per 100). The dramatic fall in disease occurrence was paralleled by improvements in sanitation, water supply, education, and access to health care in the village. Of particular importance is that the decline in trachoma occurred without any trachoma-specific intervention.

References

Jun 1, 1991·The British Journal of Ophthalmology·P CourtrightC R Dawson
Dec 1, 1989·Archives of Ophthalmology·H R TaylorP A Rapoza
Feb 1, 1989·The British Journal of Ophthalmology·H FaalA Foster
Jun 1, 1936·The British Journal of Ophthalmology·A F Maccallan

❮ Previous
Next ❯

Citations

Aug 19, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Wondu AlemayehuPaul Courtright
May 27, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·E M Harding-EschR L Bailey
Mar 17, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·Daniel YayemainMaria Hagan
Dec 6, 2001·Ophthalmology·T M Lietman
Nov 21, 2007·International Journal of Environmental Health Research·Mamadou O DialloJames A Zingeser
Aug 31, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hem JhaThomas Lietman
Nov 23, 2006·The British Journal of Ophthalmology·B ShapiroT Lietman
Apr 21, 2007·The British Journal of Ophthalmology·Hannah Kuper, Richard Wormald
Nov 26, 1998·The British Journal of Ophthalmology·P J DolinP S Lee
Sep 1, 2000·The British Journal of Ophthalmology·H FaalG J Johnson
Dec 6, 2001·The British Journal of Ophthalmology·R Dandona, L Dandona
Apr 26, 2003·The British Journal of Ophthalmology·M MeleseT M Lietman
Aug 9, 2007·BMC Infectious Diseases·Kathryn J RayThomas M Lietman
Mar 20, 2013·BMC Health Services Research·Rènée du ToitPaul Courtright
Dec 21, 2006·PLoS Medicine·John Buchan
Dec 19, 2008·PLoS Medicine·Susan Lewallen
Feb 5, 2009·PLoS Neglected Tropical Diseases·Takele LakewThomas M Lietman
Dec 23, 2009·PLoS Neglected Tropical Diseases·Emma M Harding-EschRobin L Bailey
Nov 13, 2010·PLoS Neglected Tropical Diseases·Emma M Harding-EschUNKNOWN PRET Partnership
Nov 20, 2004·Emerging Infectious Diseases·Jaya D ChidambaramThomas M Lietman
Jul 7, 2011·Middle East African Journal of Ophthalmology·Mansur M RabiuSunday Isiyaku
May 5, 1999·Lancet·P M EmersonR L Bailey
May 9, 2014·Tropical Medicine and Health·Pablo Goldschmidt, Ellen Einterz
Sep 20, 2000·Tropical Medicine & International Health : TM & IH·P M EmersonD C Mabey
Oct 31, 2000·The Pediatric Infectious Disease Journal·E MoalicA M Le Flohic
Aug 2, 2007·International Ophthalmology Clinics·Jenafir HouseTom M Lietman
Aug 23, 2002·International Ophthalmology Clinics·Bruce D GaynorTom Lietman
Dec 22, 2006·The Lancet Infectious Diseases·Deborah DeanStephen Lagree
Apr 9, 2010·Tropical Medicine & International Health : TM & IH·Victor H HuDavid C W Mabey
Mar 29, 2005·The Lancet Infectious Diseases·Jaya D ChidambaramThomas M Lietman
Jan 15, 2010·Tropical Medicine & International Health : TM & IH·S BamaniJ D King
Jun 1, 2011·Epidemics·Thomas M LietmanUNKNOWN TANA Study Group
Jul 26, 2011·Ophthalmic Epidemiology·Joseph Brima KoromaDieudonne P Sankara
Jan 1, 2010·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Imtiaz A Chaudhry
Jul 23, 2009·Expert Review of Anti-infective Therapy·Henk L Smits
Nov 13, 2007·Ophthalmic Epidemiology·Evertjan JansenPeter M Kilima
Feb 13, 2016·PLoS Neglected Tropical Diseases·Bidya Prasad PantBruce D Gaynor
Mar 27, 2004·Eye·G J Johnson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Hem JhaThomas M Lietman
Emerging Infectious Diseases
J ChidambaramThomas M Lietman
The New England Journal of Medicine
Anthony W SolomonDavid C W Mabey
© 2021 Meta ULC. All rights reserved